Name: Leucine Rich Bio Financials 2026 – Revenue, P&L & Cash Flow
Creator: Inc42 Datalabs

Leucine Rich Bio

Private

LEUCINE RICH BIO PRIVATE LIMITED

Private

LEUCINE RICH BIO PRIVATE LIMITED

2014

Founded in 2014, Leucine Rich Bio operates in Health Tech industry. Initially focused on providing genomic diagnostics services, the company has since expanded its offerings to include microbiome test...

Funding stage:

Seed

Last funding:

24/10/2023

Total funding:

$338.45K+

Revenue:

₹5.6 Cr+ (FY25)

Prev. FY

Investors

Employee count:

Last 90d

Web traffic:

6.79K

Last 30d

Glassdoor Rating:

Leucine Rich Bio: Financial Breakdown

Decoding financial health metrics of Leucine Rich Bio

Total Revenue
₹5.6 Cr
245%
Prev. FY
Total Expenses
₹5.3 Cr
143%
Prev. FY
Profit After Tax
₹37.3 Lakh
169%
Prev. FY
Total Assets
₹2.8 Cr
81%
Prev. FY
Net Profit Margin
6.7%
120%
Prev. FY

Note: Above mentioned stats are for FY24-25

FAQs on Financials of Leucine Rich Bio

No. In FY21, Leucine Rich Bio reported a net loss of ₹30.2 Lakh, so it was not profitable.

In FY21, Leucine Rich Bio posted revenue of ₹47.1 Lakh and a net loss of ₹30.2 Lakh. Explore the full financials of Leucine Rich Bio here...

Disclaimer

Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.

Quick Links

Leucine Rich Bio - Financials, Revenue, P&L Statement, Balance Sheet, Cash Flow & More

Leucine Rich Bio: Financial Breakdown

FAQs on Financials of Leucine Rich Bio

Is Leucine Rich Bio profitable?

How is Leucine Rich Bio's business performing?

Disclaimer